Is Outlook Therapeutics, Inc. technically bullish or bearish?

Sep 20 2025 07:53 PM IST
share
Share Via
As of September 9, 2025, Outlook Therapeutics, Inc. shows a neutral technical trend with mixed signals, including a bearish weekly MACD and a significant 1-year return of -83.31%, underperforming the S&P 500's 17.14%.
As of 9 September 2025, the technical trend for Outlook Therapeutics, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across various indicators. The weekly MACD is bearish, while the monthly MACD shows a mildly bullish trend. The RSI indicates no signal on the weekly timeframe but is bullish on the monthly. Moving averages are mildly bullish on the daily, but Bollinger Bands are bearish on the weekly and mildly bearish on the monthly. KST is mildly bearish weekly and bearish monthly, and there are no trends indicated by Dow Theory or OBV.

In terms of performance, the stock has significantly underperformed compared to the S&P 500 across all periods, with a 1-year return of -83.31% versus the S&P 500's 17.14%.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Outlook Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:27 PM IST
share
Share Via
Is Outlook Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:06 AM IST
share
Share Via
What does Outlook Therapeutics, Inc. do?
Jun 22 2025 06:50 PM IST
share
Share Via
How big is Outlook Therapeutics, Inc.?
Jun 22 2025 06:06 PM IST
share
Share Via